Actualizado 05/12/2007 15:12
- Comunicado -

New Data Reinforces the Superiority of Escitalopram Over Duloxetine for Acute Treatment of Depression (y 2)

-- Persistent irritability or anger that affects other people

-- Disinterest in daily activities and relationships

-- Trouble concentrating

-- Fatigue or low energy

-- Food cravings or binge eating

-- Sleep disturbances

-- Feeling out of control

-- Physical symptoms such as bloating, breast tenderness, headaches and joint or muscle pain

About Lundbeck

H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. In 2006, the company's revenue was DKK 9.2 billion (approximately EUR 1.2 billion or USD 1.6 billion). The number of employees is approximately 5,300 globally. For further information, please visit http://www.lundbeck.com.

References

1) Lam, RW et al. Escitalopram and duloxetine in the treatment of major depressive disorder - A pooled analysis. Poster presented at the 7th International Forum on Mood and Anxiety Disorders Congress, 5-7 December 2007, Budapest, Hungary

2) Wade, A. What are the future challenges in the treatment of Mood Disorders. Presented at the Lundbeck sponsored satellite symposium, 7th International Forum on Mood and Anxiety Disorders Congress, 5-7 December 2007, Budapest, Hungary

3) Wade, A et al. A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder. Curr Med Res Opin. 2007; 23 (7): 1605-1614

4) Bostwick, JM, Pakratz, VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry. 2000; 157:1925-1932

5) Depression. World Health Organisation. Last accessed on 20.11.07 from http://www.who.int/mental_health/managem...

6) Sclar, DA et al. Economic appraisal of citalopram in the management of single-episode depression. J Clin Psychopharmacol 1999; 19 (5 Suppl.1): 47S-54S

7) El-Mallakh, RS et al. Clues to depression in primary care practice. Postgraduate Medicine. 1996; 100(1): 85-8, 93-6

8) Depression. National Institute for Mental Health. Last accessed on 20.11.07 from http://www.nimh.nih.gov/health/publicati... html

9) Premenstrual dysphoric disorder. Medline Plus: Medical Encyclopaedia. Last accessed on 20.11.07 from http://www.nlm.nih.gov/medlineplus/ency/...

Media contact: For more information, please contact: Paul Gittins, Red Health, Tel: +44-207-025-6571, Mobile: +44-7958-533462, Email: paul.gittins@redconsultancy.com

Contenido patrocinado

Comunicados

Si quieres mejorar el posicionamiento online de tu marca, ahora puedes publicar tus notas de prensa o comunicados de empresa en la sección de Comunicados de europa press

Si necesitas asesoramiento en comunicación, redacción de tus notas de prensa o ampliar la difusión de tu comunicado más allá de la página web de europa press, ponte en contacto con nosotros en comunicacion@europapress.es o en el teléfono 913592600